Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025Biopharma PEG offers a comprehensive portfolio of over 4,000 PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, available in quantities from milligrams to 100 kilograms. Their diverse product line supports critical applications in the biopharmaceutical industry, including: PEGylation: Enhancing drug efficacy and delivery. LNP-based drug delivery: Facilitating the development of lipid nanoparticle formulations. ADC therapy: Providing essential linkers for antibody-drug conjugates. PROTAC development: Hydrogels: Supporting tissue engineering and drug delivery matrices. Diagnostics: "We are excited to connect with the TIDES community and showcase our broad spectrum of PEG derivatives," At Booth #913, visitors can: Explore a Wide Range of Catalog PEGs: Discover readily available products for rapid project initiation Discuss Custom Synthesis Capabilities: Understand GMP-Grade Manufacturing: Engage with the Biopharma PEG Team: Discuss specific project needs and explore potential collaborations. Biopharma PEG encourages attendees to schedule dedicated meeting times during TIDES USA 2025 to ensure personalized discussions. Please contact sales@biochempeg.com to arrange a meeting or feel free to visit Booth #913 at your convenience. End
|
|